I'm certain that you must be right Megan, because their initial study with ME patients didn't find any XMRV at all, not even in the normal population, and now they are finding XMRV in significant numbers of prostate cancer patients, and she admits that XMRV is present in 1% (her figure) of the normal population, at least in Japan anyway.
Can you remind me please, Bob, or someone else, what information has been published on the control group in the ICL/KCL study and how many?